National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

Found 253 cases where Age is under-19 and Vaccine is COVID19 and Manufacturer is PFIZER/BIONTECH and Patient Did Not Die and Hospitalized and Vaccination Date from '2021-07-01' to '2021-07-31'

Government Disclaimer on use of this data



Case Details

This is page 8 out of 26

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17   next


VAERS ID: 1518395 (history)  
Form: Version 2.0  
Age: 16.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2021-07-28
Onset:2021-07-29
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-07-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Myocarditis, Troponin increased
SMQs:, Myocardial infarction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: troponin 20.5
CDC Split Type:

Write-up: myocarditis, chest pain, elevated troponin


VAERS ID: 1519050 (history)  
Form: Version 2.0  
Age: 15.0  
Sex: Male  
Location: California  
Vaccinated:2021-07-28
Onset:2021-07-30
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-08-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EWO217 (HARD TO / 2 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Chest pain, Electrocardiogram abnormal, Laboratory test abnormal, Myocarditis, Pericarditis
SMQs:, Systemic lupus erythematosus (broad), Arrhythmia related investigations, signs and symptoms (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: 8/1 - elevated cardiac markers, and abnormal EKG. Echo will be done but pending
CDC Split Type:

Write-up: Peri/myocarditis - chest pain, pending treatment. At this point, just planning on NSAIDs


VAERS ID: 1519054 (history)  
Form: Version 2.0  
Age: 16.0  
Sex: Male  
Location: New York  
Vaccinated:2021-07-22
Onset:2021-07-24
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-08-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Hepatomegaly, Hydrocholecystis, Imaging procedure abnormal, Pain, Pleural effusion, Pyrexia
SMQs:, Liver related investigations, signs and symptoms (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Gallbladder related disorders (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness:
Preexisting Conditions: Pectus Excavatum had Nuss procedure done about 1 month ago.
Allergies: None
Diagnostic Lab Data: pleural effusion found on imaging, hepatomegaly, hydrops gallbladder concerning for an inflammatory process
CDC Split Type:

Write-up: Had high fever, chest pain, body aches


VAERS ID: 1523315 (history)  
Form: Version 2.0  
Age: 14.0  
Sex: Male  
Location: North Carolina  
Vaccinated:2021-07-26
Onset:2021-07-28
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-08-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0198 / 2 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Cardiac telemetry normal, Chest pain, Echocardiogram, Ejection fraction normal, Immunoglobulin therapy, Intensive care, Myocarditis, Pain, Pericarditis, Troponin
SMQs:, Systemic lupus erythematosus (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tylenol PRN taken for body aches and chest pain that developed after vaccine.
Current Illness: none
Preexisting Conditions: none
Allergies: Blue dye - causes vomiting
Diagnostic Lab Data: See faxed/attached documents.
CDC Split Type:

Write-up: The pt received dose 2 of the Pfizer Covid-19 vaccine on 7/26/21. The pt developed diffuse body aches the day after the vaccine which included chest pain. The second day after the vaccine his body aches were improving except for the chest pain which was progressively worsening which prompted presentation to medical care. Hospital course from discharge summary: Patient was admitted for management of myocarditis/pericarditis, presumed to be secondary to Covid immunization. On presentation, his troponin was 21.98 ng/mL with a low normal EF of 52% on formal echo at presentation on 7/29. Troponin peaked at 46.10 ng/mL on the evening of 7/29. Cardiology was consulted who provided recommendations throughout admission. He received 2 g/kg of IVIG, divided over 2 days 7/29?7/30. He was put on scheduled Toradol and received IV methylprednisolone while admitted. Echo normalized on 7/30. He was monitored on telemetry without any significant pain or abnormal rhythm changes in the 1-2 days prior to discharge. He was discharged home on oral steroids and scheduled ibuprofen until follow up with pediatric cardiology on 8/5. Patient and his mother received strict return precautions for return to care and were in agreement with the plan."


VAERS ID: 1525956 (history)  
Form: Version 2.0  
Age: 15.0  
Sex: Male  
Location: Colorado  
Vaccinated:2021-07-06
Onset:2021-07-13
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-08-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0180 / 2 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Anti-ganglioside antibody positive, Bacterial test negative, Blood immunoglobulin A normal, C-reactive protein normal, CSF oligoclonal band absent, CSF protein increased, Condition aggravated, Full blood count normal, HIV antibody negative, Headache, Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture abnormal, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal, Metabolic function test normal, Muscular weakness, Neuralgia, Neutropenia, Pain, Paraesthesia, Peroneal nerve palsy, Polyneuropathy, Red blood cell sedimentation rate normal, Respiratory viral panel, Spinal claudication, Stool analysis, Urine analysis normal, Viral test negative, Vomiting
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Agranulocytosis (broad), Haematopoietic leukopenia (narrow), Peripheral neuropathy (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None.
Current Illness: None.
Preexisting Conditions: None.
Allergies: None.
Diagnostic Lab Data: MRI (cranial and spinal): Remarkable for findings suggestive of cauda equina inflammation, including enhancement of the nerve roots and thickening without clumping. Lumbar puncture and analyses: Elevated protein in CSF. Ganglioside antibody testing: Positive for anti-GM1 and anti-GD1A antibodies. Negative or within reference ranges: complete blood count, C-reactive protein, erythrocyte sedimentation rate, HIV antibody testing, meningitis/encephalitis PCR panels, respiratory pathogen PCR panel, stool pathogen PCR panel, urinalysis, serum IgA levels, serum/CSF oligoclonal banding, comprehensive metabolic panel. All lab tests performed 7/15/21 - 7/16/21. Electromyography pending, to be performed at future date.
CDC Split Type:

Write-up: The patient is a 15 year old male in otherwise good health until he began to experience numbness, paresthesias, and weakness of the right foot on the morning of 7/13/21. He had previously received the Pfizer COVID-19 vaccine; first dose on 6/15/21 and second dose on 7/6/21. His symptoms had a waxing and waning course but progressed over the course of 3 days to include right foot drop and burning pain, prompting his father to take him to the emergency room on 7/15/21; he was admitted to the hospital and started on IV immunoglobulin with rapid resolution of his symptoms, receiving 2 total doses. See continuation page for more details. Lumbar puncture showed elevated CSF protein, and MRI findings suggested an acute inflammatory neuropathy. Hospital course was only complicated by a mild positional headache and several episodes of non-bloody non-bilious emesis, attributed to IVIG treatment. After a 3 day stay, patient was discharged on 7/18/21 to follow up at an outpatient neurology clinic for assessment and to undergo electromyography studies. Of note, the patient''s 50 year old father had experienced two episodes of progressive motor weakness and paresthesias of the extremities requiring hospitalization, including once in 2008 following a diarrheal illness, and again on 5/27/21 after receiving his first dose of the Moderna COVID-19 vaccine on 5/4/21. Both illnesses were ultimately diagnosed as autoimmune peripheral polyneuropathies and treated with IV immunoglobulin. He was assessed in the emergency room on 5/11/21 presenting with paresthesias of the left extremities and bilateral foot weakness, and left with strict return precautions without treatment or diagnostic testing. On 5/12/21 and 5/15/21 he visited a different emergency room with similar symptoms and received a lumbar puncture that showed slightly elevated protein in the CSF without leukocytes; both times he was discharged without treatment. He returned to the first hospital''s emergency room on 5/16/21 with progression of lower extremity weakness accompanied by neuropathic pain, and was referred to outpatient neurology for further assessment. On 5/27/21 he was admitted from the neurology clinic and successfully treated with 4 doses of IV immunoglobulin during a 4 day hospital stay; the fifth dose was not administered due to neutropenia. He reports gradual improvement of his symptoms with IVIG treatment and physical therapy.


VAERS ID: 1526767 (history)  
Form: Version 2.0  
Age: 14.0  
Sex: Male  
Location: Michigan  
Vaccinated:2021-07-28
Onset:2021-07-31
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-08-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0183 / 2 RA / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0183 / 1 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Electrocardiogram ST segment elevation, Fatigue, Myalgia, Myocarditis, Pyrexia, Troponin increased
SMQs:, Rhabdomyolysis/myopathy (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: buPROPion (WELLBUTRIN XL) 150 MG 24 hr tablet cetirizine (ZYRTEC) 10 MG tablet colchicine (COLCRYS) 0.6 MG tablet methylphenidate ER (CONCERTA) 54 MG controlled release tablet naproxen (NAPROSYN) 500 MG tablet
Current Illness: NA
Preexisting Conditions: Attention deficit hyperactivity disorder (ADHD), predominantly inattentive type Generalized anxiety disorder Current mild episode of major depressive disorder without prior episode (HCC) Acne vulgaris
Allergies: NKDA
Diagnostic Lab Data: Note Discussed with Dr. Troponin lab from today still pending as of 1:15pm. Hospital to call with STAT results as soon as it is processed. In the meantime, to stop Ibuprofen, start Naproxen 500mg BID x 14 days, and start Colchicine 1.2 mg BID for one day then 0.6mg BID x 6 days. OP echocardiogram to be completed on the first business day after they return from vacation. Should patient be experiencing any symptoms of chest pain or shortness of breath, to be direct admitted. Per Mom, patient is denying any shortness of breath, chest pain, or other cardiac symptoms. They return on Thursday, so OP echo to be scheduled for Friday (order placed). Reviewed the medication changes with Mom, who verbalized understanding. Thee prescriptions were sent to pharmacy per her request.
CDC Split Type:

Write-up: Myocarditis Patient is a 14 y.o. male with no past medical history who presented to the ED today due to acute chest pain. He received his second mRNA COVID vaccine on 7/28, that night he developed a fever and over the next two days had some muscle aches, fatigue and continued fevers. This morning he woke up with left sided chest pain, not reproducible and unaffected by his breathing. He denies any palpitations, shortness of breath or syncope. He was seen in urgent care which found ST elevation on EKG and sent him to HDVCH ED. EKG here confirmed ST elevation, troponin found to be elevated at 147. His chest pain improved with ibuprofen. He was admitted to cardiology service for continued monitoring. HOSPITAL COURSE: Patient is a 14 y.o. male with no past medical history who presented after 2nd mRNA COVID vaccine with chest pain, ST changes on EKG and elevated troponin. He was admitted to the cardiology service for ongoing evaluation of myocarditis. He was started on ibuprofen every 6 hours for inflammation with resolution of his pain. His ECHO demonstrated normal cardiac structure and function. EKG at time of discharge showed improvement in ST elevation. Serial troponin levels continue to be elevated, but not rapidly increasing (147, 229, 243, 267), he will get a repeat troponin tomorrow as outpatient. ID was consulted this admission and myocarditis labs are still pending. He will continue 600mg Motrin TID until troponin level improves. He will have scheduled follow up with Dr in 3 weeks.


VAERS ID: 1528683 (history)  
Form: Version 2.0  
Age: 16.0  
Sex: Male  
Location: Georgia  
Vaccinated:2021-07-12
Onset:2021-07-14
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-08-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0196 / 1 RA / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FA6780 / 2 RA / IM

Administered by: Other       Purchased by: ?
Symptoms: Cardiac stress test normal, Chest pain, Ejection fraction normal, Hyperaemia, Magnetic resonance imaging abnormal, Magnetic resonance imaging heart, Myocardial fibrosis, Troponin
SMQs:, Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ibuprofen, minocycline
Current Illness: none
Preexisting Conditions: none
Allergies: NKA
Diagnostic Lab Data: 7/28/2021:Troponin 0.460; 7/29/2021: CMRI: IMPRESSION: 1. Normal right ventricular size, RVEDV = 92 cc/m2. Normal right ventricular systolic function, RV EF = 54%. 2. Normal left ventricular size, LVEDV = 84 cc/m2. Normal left ventricular systolic function, LV EF = 58%, with no regional wall motion abnormalities. 3. No evidence of high signal intensity on T2 weighted imaging to suggest edema, T1 early post-contrast imaging to suggest hyperemia, or late gadolinium enhancement imaging to suggest myocardial fibrosis. The patient does not meet CMR criteria for myocarditis. 4. Normal origins of the left and right coronary arteries, without evidence of dilation or aneurysm. 8/4/2021: stess test, normal
CDC Split Type:

Write-up: chest pain starting 2 days after second dose


VAERS ID: 1528891 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: New York  
Vaccinated:2021-07-31
Onset:2021-08-02
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-08-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Private       Purchased by: ?
Symptoms: Brain natriuretic peptide increased, C-reactive protein increased, Cardiac imaging procedure abnormal, Chest pain, Ejection fraction decreased, Influenza A virus test negative, Influenza B virus test, Influenza virus test negative, Magnetic resonance imaging heart, Myocarditis, Myoglobin blood increased, SARS-CoV-2 test negative, Troponin increased
SMQs:, Rhabdomyolysis/myopathy (narrow), Cardiac failure (narrow), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Multivitamin Ibuprofen on the morning of 8/3
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: 8/4: Cardiac MRI - late gadolinium enhanced images demonstrate focal subepicardial linear enhancement of the myocardium and pericardium in the later and inferolateral segments. Troponin: 8/3 19:00: 11.04 ng/mL 8/3 20:30: 17.36 ng/mL 8/4 05:17: 17.94 ng/mL 8/4 11:55: 13.72 ng/mL 8/4 22:00: 12.44 ng/mL BNP 8/3 21:35: 107 pg/mL Myoglobin 8/3 20:30: 745 ng/mL CRP High Sensitivity 8/5 06:10: 50.50 mg/L SAR COV2 IgG: negative SARS COV2 PCR: Not detected Influenza A PCR: Not detected Influenza B PCR: Not detected
CDC Split Type:

Write-up: Myopericarditis confirmed by cardiac MRI and reduced ejection fraction to 50%. Patient presented to the hospital with chest pain and troponin''s were elevated up to 17.94 ng/mL. Patient remained hemodynamically stable and chest pain resolved with 650 mg of acetaminophen. Patient was initiated on captopril 6.25 three times daily while hospitalized and transitioned to lisinopril 2.5 mg upon discharge.


VAERS ID: 1529243 (history)  
Form: Version 2.0  
Age: 15.0  
Sex: Male  
Location: Virginia  
Vaccinated:2021-07-20
Onset:2021-07-22
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-08-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Chest pain, Echocardiogram normal, Electrocardiogram ST segment elevation, Troponin increased
SMQs:, Myocardial infarction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: None
Preexisting Conditions: None
Allergies: NKDA
Diagnostic Lab Data: elevated troponin, ST elevation on EKG, echo was normal
CDC Split Type:

Write-up: Chest pain, was treated with motrin, tylenol


VAERS ID: 1531600 (history)  
Form: Version 2.0  
Age: 13.0  
Sex: Female  
Location: Puerto Rico  
Vaccinated:2021-07-07
Onset:2021-07-24
   Days after vaccination:17
Submitted: 0000-00-00
Entered: 2021-08-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0181 / 2 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Arthralgia, Discoloured vomit, Dry mouth, Hypertensive crisis, Oliguria, Pain in extremity
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypertension (narrow), Arthritis (broad), Tumour lysis syndrome (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: N/A
Current Illness: N/A
Preexisting Conditions: N/A
Allergies: TORADOL
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient presents with hypertensive crisis, pain in left knee, elbow and fingers and toes. Dry mouth. Vomit is colored green. Oliguria.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=8&VAX=COVID19&VAXMAN=PFIZER/BIONTECH&HOSPITAL=Yes&DIED=No&WhichAge=range&LOWAGE=(0)&HIGHAGE=(19)&VAX_YEAR_LOW=2021&VAX_MONTH_LOW=07&VAX_YEAR_HIGH=2021&VAX_MONTH_HIGH=07


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166